BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35309299)

  • 1. Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19.
    Apostolidis SA; Sarkar A; Giannini HM; Goel RR; Mathew D; Suzuki A; Baxter AE; Greenplate AR; Alanio C; Abdel-Hakeem M; Oldridge DA; Giles JR; Wu JE; Chen Z; Huang YJ; Belman J; Pattekar A; Manne S; Kuthuru O; Dougherty J; Weiderhold B; Weisman AR; Ittner CAG; Gouma S; Dunbar D; Frank I; Huang AC; Vella LA; ; Reilly JP; Hensley SE; Rauova L; Zhao L; Meyer NJ; Poncz M; Abrams CS; Wherry EJ
    Front Immunol; 2022; 13():834988. PubMed ID: 35309299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19.
    Apostolidis SA; Sarkar A; Giannini HM; Goel RR; Mathew D; Suzuki A; Baxter AE; Greenplate AR; Alanio C; Abdel-Hakeem M; Oldridge DA; Giles J; Wu JE; Chen Z; Huang YJ; Pattekar A; Manne S; Kuthuru O; Dougherty J; Weiderhold B; Weisman AR; Ittner CAG; Gouma S; Dunbar D; Frank I; Huang AC; Vella LA; ; Reilly JP; Hensley SE; Rauova L; Zhao L; Meyer NJ; Poncz M; Abrams CS; Wherry EJ
    bioRxiv; 2021 May; ():. PubMed ID: 33972943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3.
    Watson CN; Kerrigan SW; Cox D; Henderson IR; Watson SP; Arman M
    Platelets; 2016 Sep; 27(6):535-40. PubMed ID: 27025455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease.
    Patzelt J; Mueller KA; Breuning S; Karathanos A; Schleicher R; Seizer P; Gawaz M; Langer HF; Geisler T
    Atherosclerosis; 2015 Feb; 238(2):289-95. PubMed ID: 25544179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TULA-2 (T-Cell Ubiquitin Ligand-2) Inhibits the Platelet Fc Receptor for IgG IIA (FcγRIIA) Signaling Pathway and Heparin-Induced Thrombocytopenia in Mice.
    Zhou Y; Abraham S; Renna S; Edelstein LC; Dangelmaier CA; Tsygankov AY; Kunapuli SP; Bray PF; McKenzie SE
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2315-2323. PubMed ID: 27765766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.
    Naylor-Adamson L; Chacko AR; Booth Z; Caserta S; Jarvis J; Khan S; Hart SP; Rivero F; Allsup DJ; Arman M
    Front Immunol; 2021; 12():766272. PubMed ID: 34912339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways.
    Arthur JF; Qiao J; Shen Y; Davis AK; Dunne E; Berndt MC; Gardiner EE; Andrews RK
    J Thromb Haemost; 2012 Jun; 10(6):1133-41. PubMed ID: 22489915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.
    Boylan B; Gao C; Rathore V; Gill JC; Newman DK; Newman PJ
    Blood; 2008 Oct; 112(7):2780-6. PubMed ID: 18641368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer cell-derived immunoglobulin G activates platelets by binding to platelet FcγRIIa.
    Miao S; Shu D; Zhu Y; Lu M; Zhang Q; Pei Y; He AD; Ma R; Zhang B; Ming ZY
    Cell Death Dis; 2019 Jan; 10(2):87. PubMed ID: 30692520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of C5a in sickle cell disease.
    Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
    Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of outside-in {alpha}IIb{beta}3-mediated activation of human platelets by the colonizing Bacterium, Streptococcus gordonii.
    Keane C; Petersen H; Reynolds K; Newman DK; Cox D; Jenkinson HF; Newman PJ; Kerrigan SW
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2408-15. PubMed ID: 21071690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.
    Xu GL; Chen J; Yang F; Li GQ; Zheng LX; Wu YZ
    Hepatology; 2014 Jul; 60(1):114-24. PubMed ID: 24604562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets.
    Nording H; Baron L; Haberthür D; Emschermann F; Mezger M; Sauter M; Sauter R; Patzelt J; Knoepp K; Nording A; Meusel M; Meyer-Saraei R; Hlushchuk R; Sedding D; Borst O; Eitel I; Karsten CM; Feil R; Pichler B; Erdmann J; Verschoor A; Chavakis E; Chavakis T; von Hundelshausen P; Köhl J; Gawaz M; Langer HF
    Nat Commun; 2021 Jun; 12(1):3352. PubMed ID: 34099640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet bound oxLDL shows an inverse correlation with plasma anaphylatoxin C5a in patients with coronary artery disease.
    Nording H; Giesser A; Patzelt J; Sauter R; Emschermann F; Stellos K; Gawaz M; Langer HF
    Platelets; 2016 Sep; 27(6):593-597. PubMed ID: 27025272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling network analysis reveals fostamatinib as a potential drug to control platelet hyperactivation during SARS-CoV-2 infection.
    Osmanoglu Ö; Gupta SK; Almasi A; Yagci S; Srivastava M; Araujo GHM; Nagy Z; Balkenhol J; Dandekar T
    Front Immunol; 2023; 14():1285345. PubMed ID: 38187394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
    Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
    Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway.
    Liu Y; Xu SQ; Long WJ; Zhang XY; Lu HL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7994-8003. PubMed ID: 30536348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new role for FcgammaRIIA in the potentiation of human platelet activation induced by weak stimulation.
    Canobbio I; Stefanini L; Guidetti GF; Balduini C; Torti M
    Cell Signal; 2006 Jun; 18(6):861-70. PubMed ID: 16169188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.
    Zhang K; Li GQ; He QH; Li Y; Tang M; Zheng QY; Xu GL; Zhang KQ
    Int Immunopharmacol; 2017 Dec; 53():17-23. PubMed ID: 29031143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets.
    Martel C; Cointe S; Maurice P; Matar S; Ghitescu M; Théroux P; Bonnefoy A
    PLoS One; 2011 Apr; 6(4):e18812. PubMed ID: 21526204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.